港股異動 | 申洲國際(2313.HK)漲近5% 股價再創歷史新高
格隆匯9月15日丨申洲國際(2313.HK)漲近5%,報133.2港元,股價有望實現連續6年上漲,總市值突破2000億港元。富瑞發表最新研究報告指出,供應鏈渠道調研顯示,申洲國際的口罩業務在第三季度依然強勁,同時傳統紡織品業務也比預期要強,上調目標價5.8%至145港元,維持“買入”評級。報告指出,預計優衣庫將進一步上調口罩訂單量,同時公司的生產效率將有巨大提升,9月和10月產能將維持滿負荷。富瑞分別上調申洲國際今明兩年盈利預測4%和3%。美銀證券發表研究報告,指Uniqlo 8月份銷售復甦,再次確認申洲的訂單強勁,重申“買入”評級,維持每股盈利預期,目標價由137.2港元升至147.2港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.